CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Current assets
Cash and cash equivalents	$ 696,077	$ 45,098
Marketable securities	105,314	104,215
Accounts receivable, net	16,757	8,335
Inventory	29,567	24,095
Prepaid expenses and other current assets	6,725	4,064
Total current assets	854,440	185,807
Property and equipment, net	7,581	4,712
Other assets	2,880	5,773
Total assets	864,901	196,292
Current liabilities
Accounts payable	11,465	6,337
Accrued expenses	34,122	28,742
Total current liabilities	45,587	35,079
Other liabilities	10,530	3,787
Total liabilities	56,117	38,866
Commitments and contingencies (Note 5)
Redeemable convertible preferred stock, $0.0001 par value; 0 and 91,131 shares authorized as of March 31, 2024 and December 31, 2023, respectively; 0 and 90,891 shares issued and outstanding as of March 31, 2024 and December 31, 2023, respectively; liquidation preference of $0 and $265,699 as of March 31, 2024 and December 31, 2023, respectively	0	255,127
Stockholders’ equity (deficit)
Common stock, $0.0001 par value; $1,000,000 and $162,641 shares authorized as of March 31, 2024 and December 31, 2023, respectively; $155,471 and $42,046 shares issued and outstanding as of March 31, 2024 and December 31, 2023, respectively	16	4
Additional paid-in capital	1,027,197	27,411
Accumulated other comprehensive (loss) income	(59)	259
Accumulated deficit	(218,370)	(125,375)
Total Stockholders’ Equity (Deficit)	808,784	(97,701)
Total liabilities, redeemable convertible preferred stock and stockholders’ equity (deficit)	$ 864,901	$ 196,292